How can we help?

To learn more about our services get in touch on +44 20 7246 7800 or sales@trustedsources.co.uk.

Recent China research

* China Watch: Outlook for 2018, Larry Brainard, Trey McArver, Michelle Lam, 7 Dec 2017
* China Perspective: North Korea scores, US stuck, Jonathan Fenby, 1 Dec 2017
* China Watch: The profit cycle – still some way to go, Michelle Lam, Trey McArver, Larry Brainard, 30 Nov 2017
* China Watch: China’s road to an automotive superpower, Michelle Lam, Trey McArver, Larry Brainard, Kingsmill Bond, 23 Nov 2017
* China Watch: Financial liberalisation - a step forward, Jon Harrison, Michelle Lam, Trey McArver, 16 Nov 2017

See all our China research >>

The openings in China’s pharmaceutical sector reform

Overview

China’s sheer size, ageing population, growing middle class and rapid economic development have all encouraged fantastic predictions about the potential of its healthcare and pharmaceutical markets. PricewaterhouseCoopers has forecast that China will become the world’s fifth biggest pharmaceutical market by 2010 and overtake the US as the top pharmaceutical market by 2050. Official statistics suggest total revenues of China’s pharmaceutical industry in 2006 were around US$64...

* Access to this publication is restricted

Request access

If you would like to read this publication, please enter your name and email address below:

Alternatively please call us on +44 20 7183 5280, or email sales@trustedsources.co.uk.

Already registered?